Suchergebnisse - "Fournier, Christina N"

PubPharm (36)

1

Identifying Patterns of ALS Progression from Sparse Longitudinal Data

enthalten in: bioRxiv.org | 2024

von Ramamoorthy, D. | Severson, K. | Ghosh, S. | +6

2

Network Analysis of the Cerebrospinal Fluid Proteome Reveals Shared and Unique Differences Between Sporadic and Familial Forms of Amyotrophic Lateral Sclerosis

enthalten in: bioRxiv.org | 2024

von Trautwig, A. | Fox, E. | Dammer, E. | +9

3

The importance of understanding minimal important difference for ALSFRS-R : A reply to 'Do we really need to calculate a minimal important difference for ALSFRS-R?' https://doi.org/10.1080/21678421.2023.2248199

enthalten in: Amyotrophic lateral sclerosis & frontotemporal degeneration | 2024

von Fournier, C. | Glass, J.

4

AIMing for Better Tools to Track Disease Progression

enthalten in: Neurology | 2023

von Fournier, C.

CommentOn: Neurology. 2023 Aug 8;101(6):e602-e612. - PMID 37311649

5

Clinically meaningful change : evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R

enthalten in: Amyotrophic lateral sclerosis & frontotemporal degeneration | 2023

von Fournier, C. | James, V. | Glass, J.

6

Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis

enthalten in: Muscle & nerve | 2022

von Johnson, S. | Burke, K. | Scheier, Z. | +5

7

Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data

enthalten in: Nature computational science | 2022

von Ramamoorthy, D. | Severson, K. | Ghosh, S. | +110

8

Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2022

von Fournier, C.

9

Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design

enthalten in: Neurotherapeutics | 2022

von Fournier, C.

10

Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design

enthalten in: Neurotherapeutics | 2022

von Fournier, C.